MIAMI–(BUSINESS WIRE)–CarePlus Health Plans, Inc., el plan de Medicare Advantage más grande* de Florida calificado con 5 de 5 estrellas para el 2022, está ampliando su oferta de planes para enfermedades crónicas, agregando CareBreeze (HMO C-SNP), un …
Author: Business Wire
CarePlus Introduces Medicare Advantage Plan to Benefit Floridians with Chronic Lung Conditions, Including COPD
MIAMI–(BUSINESS WIRE)–CarePlus introduces Medicare Advantage plan to benefit Floridians with chronic lung conditions, including COPD.
NovaBay Pharmaceuticals Announces Pricing of $15.0 Million Private Placement
EMERYVILLE, Calif.–(BUSINESS WIRE)—- $NBY #Avenova–NovaBay Pharmaceuticals announces pricing of $15 million private placement to fund acquisition of DERMAdoctor, LLC.
Neurotech Pharmaceuticals Appoints Thomas Aaberg Jr., M.D. as Chief Medical Officer
CUMBERLAND, R.I.–(BUSINESS WIRE)–Neurotech Pharmaceuticals, a biotechnology company developing transformational, sight-saving therapeutics for the treatment of chronic eye diseases, announced today that Thomas Aaberg, Jr., M.D. has been appointed to …
Ocular Therapeutix™ to Present Data at the American Academy of Optometry Annual Meeting 2021
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announc…
2021 Report on the Keratoconjunctivitis Sicca Drugs In Development – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Keratoconjunctivitis Sicca (Ophthalmolo…
Sam’s Club and Walmart to Launch First Eyewear Collection Created by the Legendary Elton John
BENTONVILLE, Ark.–(BUSINESS WIRE)–Elton John Eyewear, a new line of stylish, accessible eyewear, is launching at Sam’s Club today and at Walmart later this week. Elton John collaborated closely with the retailers on the development of the brand, with…
Ocular Therapeutix™ To Report Third Quarter 2021 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
Aura Biosciences Announces Pricing of Initial Public Offering
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, Inc. (“Aura”), a clinical-stage oncology company developing a novel class of virus-like drug conjugate therapies for multiple oncology indications, today announced the pricing of its initial public o…
Warby Parker Announces Third Quarter Fiscal 2021 Earnings Conference Call
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE:WRBY), a founder-led direct-to-consumer eyewear brand, today announced that its financial results for the third quarter fiscal 2021 will be released before market open on Friday, November 12, 2021. In …
CURACLE en Théa maken licentie- en samenwerkingsovereenkomst bekend voor de ontwikkeling en vercommercialisering van een oraal toe te dienen behandeling voor diabetisch macula-oedeem en natte AMD
SEOUL, Zuid-Korea–(BUSINESS WIRE)–CURACLE, een in Korea gevestigd biofarmaceutisch bedrijf heeft vandaag bekendgemaakt dat het een exclusieve licentie- en samenwerkingsovereenkomst is aangegaan met Théa Open Innovation, het dochterbedrijf van Théa, E…
Europe Dry Eye Market and Competitive Landscape Report 2021-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Dry Eye Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Europe Dry Eye Market and Competitive Landscape – 2021, provides comprehensive insights into Dry Eye pipel…
Europe Age-Related Macular Degeneration Market and Competitive Landscape Report 2021-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Age-Related Macular Degeneration Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Europe Age-Related Macular Degeneration Market and Competitive Landscape – 2021, …
CURACLE y Théa anuncian un acuerdo de licencia y colaboración para el desarrollo y comercialización de un tratamiento de administración oral para el edema macular diabético y la degeneración macular exudativa asociada a la edad
SEÚL, Corea del Sur–(BUSINESS WIRE)–CURACLE, una empresa biofarmacéutica coreana, ha anunciado hoy que ha firmado un acuerdo exclusivo de licencia y colaboración con Théa Open Innovation (TOI), la empresa asociada de Théa, la compañía oftalmológica i…
CURACLE et Théa annoncent un accord de licence et de collaboration pour le développement et la commercialisation d'un traitement administré par voie orale pour l'œdème maculaire diabétique et la DMLA humide
SÉOUL, Corée du Sud–(BUSINESS WIRE)–CURACLE, une société biopharmaceutique basée en Corée, a annoncé aujourd’hui avoir conclu avec Théa Open Innovation, la société sœur de Théa, le numéro un européen de l’ophtalmologie indépendante fort de 150 ans d’…
Ocular Therapeutix™ to Present Data at the American Academy of Ophthalmology (AAO) 2021 Virtual Annual Meeting
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announc…
IACTA Pharmaceuticals Receives U.S. Department of Defense Funding of $1 Million to Conduct Preclinical Studies of IC 800 to Treat Pain Relief for Eye Injury
GUAYNABO, Puerto Rico–(BUSINESS WIRE)–IACTA Receives U.S. Department of Defense Funding of $1 Million to Conduct Preclinical Studies of IC 800 to Treat Pain Relief for Eye Injury
Aerie Pharmaceuticals to Announce Third Quarter 2021 Financial Results and Host Conference Call on Thursday, November 4, 2021
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company, announced today that its third quarter 2021 financial results will be released after the market closes on Thursday, November 4, 2021. Follo…
Tilak Healthcare Raises €7m to Deploy Its Remote Vision Monitoring Platform
PARIS–(BUSINESS WIRE)– #chronicdisease–Tilak Healthcare, a pioneering company developing mobile games with medical modules to monitor patients with chronic ophthalmological conditions, has announced a €7 million fundraising round managed by Elaia, w…
Aldeyra Therapeutics Reports Third-Quarter 2021 Financial Results and Recent Corporate Highlights
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today reported recent corporate highlights and financial…